LI
TECH icon

LMCG Investments’s Bio-Techne TECH Stock Holding History

LMCG Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,039
Closed -$934K – 281
2024
Q2 		$934K Sell
13,039
-67
-0.5% -$4.93K 0.05% 193
2024
Q1 		$923K Sell
13,106
-10,662
-45% -$763K 0.05% 210
2023
Q4 		$1.83M Hold
23,768
– – 0.11% 160
2023
Q3 		$1.62M Buy
23,768
+500
+2% +$39.5K 0.11% 167
2023
Q2 		$1.9M Hold
23,268
– – 0.12% 159
2023
Q1 		$1.73M Buy
23,268
+8,199
+54% +$632K 0.12% 164
2022
Q4 		$1.25M Buy
15,069
+29
+0.2% +$2.3K 0.09% 194
2022
Q3 		$1.07M Buy
15,040
+7,432
+98% +$642K 0.08% 219
2022
Q2 		$659K Buy
7,608
+1,096
+17% +$103K 0.05% 254
2022
Q1 		$705K Buy
+6,512
New +$672K 0.04% 258

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LMCG Investments's TECH Position: Q3 2024 in Review

LMCG Investments sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 13,039 shares — an estimated $934K sold.

LMCG Investments first reported a position in TECH in Q1 2022 and held it in 10 quarters. The position peaked at $1.9M in Q2 2023. 562 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

  • LMCG Investments reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
  • LMCG Investments sold 13,039 Bio-Techne shares in Q3 2024, an estimated $934K.
  • LMCG Investments first reported a position in Bio-Techne in Q1 2022 and held it in 10 quarters.
  • LMCG Investments's Bio-Techne position peaked at $1.9M in Q2 2023.
  • 562 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on LMCG Investments's 13F filing for Q3 2024, filed 29 Oct 2024.